Literature DB >> 18453607

Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses.

Gonzalo de la Rosa1, De Yang, Poonam Tewary, Atul Varadhachary, Joost J Oppenheim.   

Abstract

Lactoferrin is an 80-kDa iron-binding protein present at high concentrations in milk and in the granules of neutrophils. It possesses multiple activities, including antibacterial, antiviral, antifungal, and even antitumor effects. Most of its antimicrobial effects are due to direct interaction with pathogens, but a few reports show that it has direct interactions with cells of the immune system. In this study, we show the ability of recombinant human lactoferrin (talactoferrin alfa (TLF)) to chemoattract monocytes. What is more, addition of TLF to human peripheral blood or monocyte-derived dendritic cell cultures resulted in cell maturation, as evidenced by up-regulated expression of CD80, CD83, and CD86, production of proinflammatory cytokines, and increased capacity to stimulate the proliferation of allogeneic lymphocytes. When injected into the mouse peritoneal cavity, lactoferrin also caused a marked recruitment of neutrophils and macrophages. Immunization of mice with OVA in the presence of TLF promoted Th1-polarized Ag-specific immune responses. These results suggest that lactoferrin contributes to the activation of both the innate and adaptive immune responses by promoting the recruitment of leukocytes and activation of dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453607      PMCID: PMC2408856          DOI: 10.4049/jimmunol.180.10.6868

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  [Preparation and properties of lactosiderophilin (lactotransferrin) of human milk].

Authors:  J MONTREUIL; J TONNELAT; S MULLET
Journal:  Biochim Biophys Acta       Date:  1960-12-18

Review 2.  Antimicrobial proteins act as "alarmins" in joint immune defense.

Authors:  De Yang; Joost J Oppenheim
Journal:  Arthritis Rheum       Date:  2004-11

Review 3.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 4.  Alarmins: chemotactic activators of immune responses.

Authors:  Joost J Oppenheim; De Yang
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

5.  A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic.

Authors:  P P Ward; C S Piddington; G A Cunningham; X Zhou; R D Wyatt; O M Conneely
Journal:  Biotechnology (N Y)       Date:  1995-05

6.  Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles.

Authors:  H Moed; T J Stoof; D M Boorsma; B M E von Blomberg; S Gibbs; D P Bruynzeel; R J Scheper; T Rustemeyer
Journal:  Clin Exp Allergy       Date:  2004-12       Impact factor: 5.018

Review 7.  Lactoferrin: an important host defence against microbial and viral attack.

Authors:  P Valenti; G Antonini
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

8.  Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.

Authors:  Kahori Kurosaka; Qian Chen; Felix Yarovinsky; Joost J Oppenheim; De Yang
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

Review 9.  Lactoferrin: a modulator of immune and inflammatory responses.

Authors:  D Legrand; E Elass; M Carpentier; J Mazurier
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

10.  Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.

Authors:  M C Dieu; B Vanbervliet; A Vicari; J M Bridon; E Oldham; S Aït-Yahia; F Brière; A Zlotnik; S Lebecque; C Caux
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  53 in total

1.  NSCLC - immunogenic after all?

Authors:  Karl-Josef Kallen; Ulrike Gnad-Vogt
Journal:  J Thorac Dis       Date:  2011-06       Impact factor: 2.895

2.  Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop.

Authors:  Stacy J Park; Marie D Burdick; William K Brix; Mark H Stoler; David S Askew; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

3.  CHO expressed recombinant human lactoferrin as an adjuvant for BCG.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int J Immunopathol Pharmacol       Date:  2015-08-27       Impact factor: 3.219

4.  Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin.

Authors:  Irini Bournazou; John D Pound; Rodger Duffin; Stylianos Bournazos; Lynsey A Melville; Simon B Brown; Adriano G Rossi; Christopher D Gregory
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

5.  Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

Authors:  William C Adams; Emily Bond; Menzo J E Havenga; Lennart Holterman; Jaap Goudsmit; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

Review 6.  Phagocyte partnership during the onset and resolution of inflammation.

Authors:  Oliver Soehnlein; Lennart Lindbom
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 7.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

8.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

9.  Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors.

Authors:  Teresa G Hayes; Gerald S Falchook; Atul Varadhachary
Journal:  Invest New Drugs       Date:  2009-02-24       Impact factor: 3.850

10.  Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.

Authors:  Kathryn A Patras; Albert D Ha; Emma Rooholfada; Joshua Olson; Satish P Ramachandra Rao; Ann E Lin; Victor Nizet
Journal:  J Innate Immun       Date:  2019-05-03       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.